Deadly coronavirus itself is not enough that a new strain of coronavirus is

detected in Malaysia named D614G and found to be ten times deadlier or

infectious than the original Wuhan strain according to the country's Health
Ministry.

The Director-General of the country's Health Ministry Noor Hisham

Abdullah said the community had to be more careful after a D614G
mutation of the novel coronavirus was detected.

A highly infectious mutation of the virus has been detected in Malaysia

Sunday (16 August, 2020), when the tally of cases stood at around 9,200.
The Institute of Medical Research in Malaysia has detected D614G type
mutation as a result of isolation and culture tests. In three cases the
mutation has been spotted from a cluster. 

What is the difference between Corona Kavach Policy and Corona

Rakshak Policy?
From where D614G came?
Three cases from the Shivaganga patient under investigation (PUI)
Cluster and one case from the Ulu Tiram Cluster in Malaysia are found.

In 45 cases in a cluster, the mutation known as D614G was found in at

least three that started from an owner of a restaurant named Nezar
Mohamed Sabur Batca returned from India and breaching his 14-day
home quarantine. He has been sentenced to five months in prison and
fined. In another cluster, the strain was also found involving people
returning from the Philippines.

What is D614G strain?

According to the Health Director-General Datuk Dr. Noor Hisham
Abdullah, the D614G mutation has been detected in Malaysia and found
to be ten times easier to infect other individuals and also easier to spread.
So far, these clusters have been found to be under control as a result of
swift public health control actions. As per Abdullah, the strain could be
mean that the existing studies on vaccines might be incomplete or
ineffective against the mutation.

But as per the World Health Organisation there is no evidence the strain
leads to more severe disease. In Cell Press a paper is published and said
about mutation which is unlikely to have a major impact on the efficacy of
vaccines currently being developed.